Home » Novavax Losses Rise on R&D Costs
Novavax Losses Rise on R&D Costs
Novavax Inc. saw losses rise 80 percent last quarter as it spent more money developing experimental influenza vaccines.
Washington Business Journal
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May